Samer Alsaid: Warfarin Outcomes Reassessed Through COMBINE AF
Samer Alsaid, Cardiologist and Vascular Medicine Specialist, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in JACC: Advances, adding:
“Some projects become more than just papers.
Three years ago, my first project at the TIMI Study Group began with a long-standing idea of Dr. Eugene Braunwald.
He had long recognized that we had one of the world’s largest collections of patients treated with warfarin from the pivotal atrial fibrillation trials—and a unique opportunity to answer questions that remain clinically relevant today, including whether there are patients for whom warfarin may still be a reasonable option, particularly where access to DOACs is limited.
Three years later, that work has culminated in two companion papers from the COMBINE AF collaboration, now published in JACC: Advances.
Dr. Braunwald mentored this work every step of the way—with calls, ideas, and thoughtful edits—until the very end.
Sadly, he did not live to see these papers published.
His mentorship, intellectual curiosity, and unwavering commitment to improving patient care will stay with me for the rest of my career.”
Title: Outcomes With Warfarin in Atrial Fibrillation: Individual Patient Data Analysis From Four Randomized Trials
Authors: Samer AlSaid, Eugene Braunwald, Elaine M. Hylek, Michael G. Palazzolo, Andrea Bellavia, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Manesh R. Patel, Lars Wallentin, Christian T. Ruff, Robert P. Giugliano
Read the full article on JACC: Advances.
Title: Heterogeneity of Treatment Effect of DOACs vs Warfarin in Atrial Fibrillation
Authors: Samer Al Said, Andrea Bellavia, Eugene Braunwald, Elaine M. Hylek, Michael G. Palazzolo, Hwanhee Hong, Elliott M. Antman, Anthony P. Carnicelli, John W. Eikelboom, Christopher B. Granger, Manesh R. Patel, Lars Wallentin, Christian T. Ruff, Robert P. Giugliano
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 14, 2026, 11:16Zahra Ghasemi: Breaking the Freezer Barrier in Plasma Transfusion
-
Sep 14, 2026, 09:44Mohammad Salar Amoli: Thrombin The Master Regulator of Coagulation
-
Sep 14, 2026, 09:23Claire Harrison: HemaSphere Introduces New Patient Editor Role
-
Sep 14, 2026, 09:13Eirini Zorba: Plasmapheresis in Focus Understanding Its Role in Patient Care
-
Sep 14, 2026, 08:55Abdulrahman Al-Mashdali։ Immune Checkpoint Inhibitor Associated HLH
-
Sep 14, 2026, 07:54Islam Sadek: SOHO2026 Highlights Advances in Hematologic Malignancies
-
Sep 14, 2026, 07:45Flora Peyvandi: Building a More Equitable Future for Hemophilia Care
-
Sep 14, 2026, 07:37Joseph Pierre Aboumsallem: ET Treatment Enters a New Chapter
-
Sep 14, 2026, 07:29Eric Topol: Will AI Replace Clinicians?